Curing Deadly Human Diseases
Discovering Novel Targets and Therapeutics
AI-Powered Precision Medicine
We use advanced Artificial Intelligence platform to discover novel targets and therapeutics against fatal human diseases.
Our mission
Our mission is to create safer, innovative and better therapeutics for cures of deadly human diseases, making mankind live longer, healthier and happier by revealing the unknown existence.
Our approach
PATHTM (Precision Medicine Artificial Intelligence Therapeutics Development) platform speaks for our approach itself. PATHTM centered on a proprietary AI model to integrate big ‘omics’ data from human disease samples and single cells to discover novel druggable targets and predict precision therapeutics.
The therapeutics are refined and validated using an iterative framework with PathTM and translatable biological models to develop clinical trials optimized for efficacy and successful approval.
EXPLORE OUR APPROACH
Our pipeline
We are currently developing multiple small-molecule drugs for treatment of neurodegenerative diseases, cancer and auto-immune diseases into clinical trials.
Our team
We are a highly inter-disciplinary team. All team members are tenured faculty with decades of deep research experiences and well-funded federal research grants. Our expertise range from AI/Machine Learning, biology, pharmacology and biomedicine chemistry. We are currently developing multiple small-molecule drugs for treatment of neurodegenerative diseases, cancer, healthy aging and auto-immune diseases into clinical trials.